Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line.
Treatment of MCF-7 cells with 12-O-tetradecanoylphorbol 13-acetate (TPA) results in an inhibition of cell proliferation and a reduction in the number of estrogen receptors (ER), shown by binding studies and immunoassay. The decrease in ER concentration induced by phorbol ester derivatives parallels their growth inhibitory effect. Moreover, the estrogen receptor of TPA-resistant RPh4 cells (which are insensitive to the antiproliferative and morphological effects of TPA) is not affected by TPA treatment. The reduction in ER concentration appear to be a specific phenomenon since it contrasted with the 2-fold increase in total cell protein content which included an increase in progesterone receptor (PgR). We also found that addition of TPA does not affect estrogen induction of PgR.
Guilbaud
N
N
INSERM U168, Departement d'Endocrinologie, CHU Rangueil, Université Paul Sabatier, Toulouse, France.
Pichon
M F
MF
Faye
J C
JC
Bayard
F
F
Valette
A
A
D001667:Binding, Competitive; D001940:Breast / Q000166:cytology / Q000378:metabolism*; D002460:Cell Line; D005260:Female; D006801:Humans; D011960:Receptors, Estrogen / Q000187:drug effects*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
D011960:Receptors, Estrogen; D013755:Tetradecanoylphorbol Acetate